Gordon Duff

Chairman, Scientific Advisory Board at Silence Therapeutics Plc

Sir Gordon Duff, M.D., Ph. D., is the President of the United in Diversity Foundation working towards the UN's Sustainable Development Goals and creating an international campus at Kura Kura Island, Bali. He is co-chair (with Prof Andrew Lo, MIT) of the recently launched $30 billion 'Health of Nations' investment fund. He previously served as the Principal of St. Hilda's College at the University of Oxford and as Chair of the UK's Committee on Safety of Medicines and its Biologicals and Vaccines Sub-committee as well as inaugural Chair of the UK's Commission on Human Medicines. Sir Gordon is an expert on healthcare and UK science policy with a special interest in the genetics of the inflammatory response and was the co-founding editor of the international research journal CYTOKINE, advisory editor to the Human Genome Organisation (HUGO) journal, and is Past-President of the International Cytokine Society. He was Knighted for services to Public Health in 2007, has more than 450 peer-reviewed publications, and was listed in the Top 100' working scientists in the UK Science Council's list for 2014. He was also previously Chair of the Biotechnology and Biological Science Research Council (BBSRC) and of the UK's Medicines and Healthcare products Regulatory Agency (MHRA), and so brings deep insights and a regulatory perspective of biopharma, drug discovery, and drug development.

Timeline

  • Chairman, Scientific Advisory Board

    Current role